U.s. Physical Therapy (USPH)
NYSE:USPH
Want to see USPH full AI Analyst Report?
USPH Stock Chart & Stats
$76.57
$0.25(0.28%)
At close: 4:00 PM EST
$76.57
$0.25(0.28%)
Day’s Range― - ―
52-Week Range$58.19 - $93.50
Previous CloseN/A
Volume11.83K
Average Volume (3M)154.56K
Market Cap
$951.17M
Enterprise Value$1.31B
Total Cash (Recent Filing)$28.44M
Total Debt (Recent Filing)$362.83M
Price to Earnings (P/E)803.3
Beta0.97
Next Earnings
Jul 30, 2026EPS Estimate
0.85Next Dividend Ex-DateN/A
Dividend Yield2.25%
Share Statistics
EPS (TTM)0.50
Shares Outstanding15,218,789
10 Day Avg. Volume151,871
30 Day Avg. Volume154,560
Financial Highlights & Ratios
PEG Ratio-3.45
Price to Book (P/B)2.49
Price to Sales (P/S)1.52
P/FCF Ratio19.43
Enterprise Value/Market Cap1.38
Enterprise Value/Revenue1.80
Enterprise Value/Gross Profit8.80
Enterprise Value/Ebitda12.48
Forecast
1Y Price Target
$95.00Price Target Upside24.07% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)2.89
Revenue Forecast (FY)$838.68M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue Growth And Cash GenerationMulti-year top-line growth alongside meaningful operating cash flow and positive free cash flow creates durable internal funding for clinic expansions, de novo openings, dividends and M&A. Strong cash generation cushions execution risk and supports capital allocation over the next several quarters.
High-margin Industrial Injury Prevention (IIP) GrowthIIP is a faster-growing, higher-margin business that diversifies revenue beyond outpatient PT. Its expanding employer contracts and margin improvement materially bolster enterprise profitability potential and provide recurring contracted cash flows that are less seasonal than clinic visits.
Improved Financing Flexibility Via $450M FacilityAn upsized, five-year credit facility extends maturities and increases acquisition and working-capital capacity. Enhanced liquidity reduces near-term refinancing risk and provides firepower for M&A, de novo growth and partnership investments that underpin medium-term scale advantages.
Bears Say
Compressed Profitability And Weak ReturnsSignificant erosion of net margin and ROE despite revenue growth signals structural pressure on bottom-line economics. Persistently low returns reduce reinvestment efficiency and increase sensitivity to cost or reimbursement shocks, constraining durable shareholder value creation.
Operating Cost Pressure Lowering PT MarginsRising payroll, contract labor and other per-visit costs compress core physical therapy margins. If higher cost structure persists, margin recovery will depend on sustained rate capture, productivity gains from tech initiatives, or structural reductions in labor intensity—none guaranteed quickly.
Payor Mix And Reimbursement Risk (Medicaid/Medicare Exposure)Significant exposure to government and regional payor rate changes means revenue per visit can be volatile and structurally constrained. Medicaid rate headwinds and only modest Medicare uplifts limit margin tailwinds and require operational offsets to sustain profitability.
US Physical Therapy News
USPH FAQ
What was U.s. Physical Therapy’s price range in the past 12 months?
U.s. Physical Therapy lowest stock price was $58.19 and its highest was $93.50 in the past 12 months.
What is U.s. Physical Therapy’s market cap?
U.s. Physical Therapy’s market cap is $951.17M.
When is U.s. Physical Therapy’s upcoming earnings report date?
U.s. Physical Therapy’s upcoming earnings report date is Jul 30, 2026 which is in 56 days.
How were U.s. Physical Therapy’s earnings last quarter?
U.s. Physical Therapy released its earnings results on May 06, 2026. The company reported $0.46 earnings per share for the quarter, missing the consensus estimate of $0.517 by -$0.057.
Is U.s. Physical Therapy overvalued?
According to Wall Street analysts U.s. Physical Therapy’s price is currently Undervalued.
Does U.s. Physical Therapy pay dividends?
U.s. Physical Therapy pays a Quarterly dividend of $0.45 which represents an annual dividend yield of 2.25%. See more information on U.s. Physical Therapy dividends here
What is U.s. Physical Therapy’s EPS estimate?
U.s. Physical Therapy’s EPS estimate is 0.85.
How many shares outstanding does U.s. Physical Therapy have?
U.s. Physical Therapy has 15,218,789 shares outstanding.
What happened to U.s. Physical Therapy’s price movement after its last earnings report?
U.s. Physical Therapy reported an EPS of $0.46 in its last earnings report, missing expectations of $0.517. Following the earnings report the stock price went down -19.891%.
Which hedge fund is a major shareholder of U.s. Physical Therapy?
Currently, no hedge funds are holding shares in USPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
US Physical Therapy Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$95.00 (24.07% Upside)
$95.00 (24.07% Upside)
Blogger Sentiment
Bearish
USPH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 132.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $148.7K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.22%
12-Months-Change
Fundamentals
Return on Equity
0.24%
Trailing 12-Months
Asset Growth
5.29%
Trailing 12-Months
Company Description
U.s. Physical Therapy
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
USPH Company Deck
USPH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated solid top-line growth, strengthening visit trends, and strategic progress (IIP margin expansion, hospital affiliations starting, expanded credit facility and targeted technology/ cash-program rollouts). Near-term pressures—weather-related lost visits, higher operating and corporate costs, elevated tax rate, and GAAP per-share impacts from revaluations—temporarily weighed on margins and net income. Management affirmed full-year adjusted EBITDA guidance, highlighted recoveries as seasonality normalizes and hospital ramps accelerate, and presented confidence in execution of strategic initiatives.View all USPH earnings summariesUSPH Stock 12 Month Forecast
Average Price Target
$95.00
▲(24.07% Upside)
Technical Analysis
AMN Healthcare Services
―
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
Pennant Group
―
Ownership Overview
2.28% Insiders
29.26% Mutual Funds
35.24% Other Institutional Investors
7.52% Public Companies and
Individual Investors